| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
650 |
628 |
$194K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
845 |
827 |
$73K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
124 |
124 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
170 |
169 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
170 |
169 |
$9K |
| 87428 |
|
39 |
39 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
277 |
268 |
$3K |
| 81025 |
|
283 |
277 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
152 |
152 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
57 |
57 |
$2K |
| 99051 |
|
83 |
83 |
$2K |
| 81002 |
|
474 |
465 |
$2K |
| 80053 |
Comprehensive metabolic panel |
70 |
68 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
79 |
79 |
$875.89 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43 |
43 |
$790.15 |
| 87081 |
|
12 |
12 |
$109.44 |